|
03.12.2024 15:00:20
|
Purple Biotech Announces $2.8 Mln ADS Offering, Pre-Market Stock Down Over 28%
(RTTNews) - Purple Biotech Ltd. (PPBT), a drug maker focused on tumor immune evasion and drug resistance, on Tuesday announced a registered direct offering of 472,668 of American Depositary Shares or ADSs at $6 per ADS. Each ADS represents 200 shares.
The gross proceeds from the offering, to be closed on or about December 4, are expected to be around $2.8 million.
Purple Biotech intends to use the net proceeds to fund the development of its oncology therapeutic candidates, and for general working capital and corporate purposes. PPBT was down by 28.57 percent at $6 in the pre-market trade on the Nasdaq.
Analysen zu Purple Biotech Ltd (spons. ADRs)
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ LPL Finance
✅ Blackstone
✅ Ares Management
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
SMI stabil -- DAX fester -- Börsen in Fernost letztlich mehrheitlich im PlusDer heimische Aktienmarkt zeigt sich am Donnerstag wenig bewegt. Der deutsche Aktienmarkt notiert etwas höher. Asiens Börsen verbuchten am Donnerstag überwiegend Gewinne.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |